Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€1.50
14.04.24
€1.00
14.04.25
12.53%
17.04.24

Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.51
14.04.24
-
14.04.25
-0.66%
28.04.24

buy
Globe Life Inc.

Start price
Target price
Perf. (%)
€55.50
14.04.24
-
14.04.25
27.03%
27.04.24

Could be worthwhile Investment >10% per year
buy
Liberty Media Corp.

Start price
Target price
Perf. (%)
€24.00
14.04.24
-
14.05.24
-0.83%
16.04.24

Micron Technology Inc.

Start price
Target price
Perf. (%)
€114.20
14.04.24
-
14.04.25
-10.49%
22.04.24

buy
Informatica Inc.

Start price
Target price
Perf. (%)
€38.80
14.04.24
-
14.04.25
-22.14%
27.04.24

Could be worthwhile Investment >10% per year
buy
Heidelberger Druckmaschinen AG

Start price
Target price
Perf. (%)
€1.01
13.04.24
-
13.04.25
-10.57%
27.04.24

buy
Fanuc Corp.

Start price
Target price
Perf. (%)
€26.67
13.04.24
-
13.04.25
1.99%
27.04.24

buy
Tilray Inc

Start price
Target price
Perf. (%)
€1.70
13.04.24
-
13.04.25
-1.21%
27.04.24

buy
Epigenomics AG

Start price
Target price
Perf. (%)
€1.57
13.04.24
-
13.04.25
-2.23%
27.04.24

buy
Vodafone Group

Start price
Target price
Perf. (%)
€0.81
13.04.24
-
13.04.25
-
13.04.24

buy
Varta AG

Start price
Target price
Perf. (%)
€9.43
13.04.24
-
13.04.25
-0.32%
27.04.24

buy
Q32 Bio Inc.

Start price
Target price
Perf. (%)
€14.94
13.04.24
-
13.04.25
-
27.04.24

Could be worthwhile Investment >10% per year
buy
Entera Bio

Start price
Target price
Perf. (%)
€2.32
13.04.24
-
13.04.25
-19.83%
27.04.24

Could be worthwhile Investment >10% per year
Liquidia Technologies Inc

Start price
Target price
Perf. (%)
€13.78
13.04.24
€12.00
13.04.25
-18.00%
27.04.24

Probably not worthwhile Investment
EBIT decline/stagnation expected
Low dividend yield expected
Revenue decline/stagnation expected
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.07
13.04.24
€1.00
13.04.25
-2.80%
27.04.24

Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year
Inotiv Inc.

Start price
Target price
Perf. (%)
€5.50
13.04.24
€4.00
13.04.25
-32.36%
27.04.24

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Little Investments for future growth
Cassava Sciences Inc.

Start price
Target price
Perf. (%)
€22.07
13.04.24
€2.00
13.04.25
-5.44%
27.04.24

Probably not worthwhile Investment
EBIT decline/stagnation expected
negative Cash Flow expected
Bad rating
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.51
13.04.24
€2.00
13.04.25
-0.66%
27.04.24

negative Cash Flow expected
Few uniques
Growths slower than the competition
Below average Marketposition
buy
Entera Bio

Start price
Target price
Perf. (%)
€2.32
13.04.24
€3.00
13.04.25
-19.83%
27.04.24

buy
Anebulo Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.72
13.04.24
€3.00
13.04.25
-7.35%
27.04.24

buy
Alterity Therapeutics Ltd. ADR

Start price
Target price
Perf. (%)
€3.80
13.04.24
€2.00
13.04.25
-56.84%
27.04.24

buy
Protagenic Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.26
13.04.24
€2.00
13.04.25
2.38%
27.04.24

buy
Adicet Bio Inc.

Start price
Target price
Perf. (%)
€1.97
13.04.24
€20.00
13.04.25
-14.68%
27.04.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
EBIT growth > 30% per year expected
buy
Aperam S.A.

Start price
Target price
Perf. (%)
€29.36
13.04.24
-
13.04.25
-4.29%
27.04.24